✦ LIBER ✦

Fatal bleomycin toxicity from a low cumulative dose in a patient with renal insufficiency

✍ Scribed by Beverly F. McLeod; H. Jeffrey Lawrence; David W. Smith; Phillip J. Vogt; David R. Gandara

Publisher: John Wiley and Sons
Year: 1987
Tongue: English
Weight: 372 KB
Volume: 60
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19871201)60:11<2617::aid-cncr2820601107>3.0.co;2-d

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cerebellar toxicity with medium-dose cyt

Cerebellar toxicity with medium-dose cytarabine in a young patient with renal insufficiency

✍ Chim, C.S.; Kwong, Y.L. 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 147 KB 👁 1 views

a patient with myelodysplastic syndrome and acute myeloid leukemia evolving from polycythemia Vera (PV) treated with hydroxyurea for 4 years. A 43-year-old man presented with facial erythrosis and intense itching in June 1991. Physical examination revealed splenomegaly. Complete blood count reveale

Valvular heart disease in a patient with

Valvular heart disease in a patient with Parkinson's disease treated with a low daily dose and a low cumulative dose of pergolide

✍ Eun Joo Chung; Won Tae Yoon; Ji-Youn Kim; Won Yong Lee 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 102 KB 👁 1 views

Evaluation of low dose continuous infusi

Evaluation of low dose continuous infusion 5-fluorouracil in patients with advanced and recurrent renal cell carcinoma. A Southwest Oncology Group study

✍ Julie A. Kish; Michael Wolf; E. David Crawford; Joseph T. Leimert; Anton Buesche 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 289 KB 👁 2 views

Background. The response rate of metastatic renal cell cancer to cytotoxic therapy over the last 10 years has been 5.6%. Low dose continuous 5-fluorouracil(5-FU) has demonstrated efficacy in other cytotoxic refractory tumors, such as pancreas, colorectal, and recurrent breast. The Southwest Oncology

Improved tolerability and quality of lif

Improved tolerability and quality of life with maintained efficacy using twice-daily low-dose interferon-α-2b : Results of a randomized phase II trial of low-dose versus intermediate-dose interferon-α-2b in patients with metastatic renal cell carcinoma

✍ Nizar M. Tannir; Lorenzo Cohen; Xuemei Wang; Peter Thall; Paul F. Mathew; Eric J 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 132 KB 👁 2 views

Feasibility and toxicity of high-dose th

Feasibility and toxicity of high-dose therapy (HDT) supported by peripheral blood stem cells in elderly patients with multiple myeloma and non-Hodgkin's lymphoma: Survey from a single institution

✍ Massimo Magagnoli; Luca Castagna; Monica Balzarotti; Barbara Sarina; Inna Timofe 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 71 KB 👁 2 views